Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the University of Oxford, the world’s #1 research university. 

This partnership enables us to work with the brightest academic minds tackling the world’s toughest challenges and guarantees us unrivalled access to their scientific research. In collaboration with our global network of entrepreneurs and advisors, we go well beyond funding to shape and nurture these complex ideas into successful businesses. 

Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, Deep Tech – we adopt a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience.

To date, we have invested £0.6 billion in over 80 ambitious companies built on Oxford science, helping progress >50 from seed to Series A, and >20 to Series B and beyond, including 2 IPOs and 7 trade sales. 

A key player in Oxford’s entrepreneurial ecosystem, we are highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. We are committed to doing this in an inclusive and sustainable way.

Oxford Science Enterprises

Deep Science Ventures is a venture capital firm specializing in life sciences and deep tech investments. The firm focuses on creating and investing in companies that leverage scientific breakthroughs and transformative technologies.

Deep Science Ventures

Abingworth is a leading international investment group dedicated to life sciences. The firm invests in a broad range of life science companies, including biotechnology, pharmaceuticals, and medical technology.

Abingworth

Balderton Capital is a venture capital firm that invests in early-stage technology companies across Europe. The firm focuses on backing ambitious entrepreneurs in the life sciences and deep tech sectors.

Balderton Capital

Merit Capital Partners is a private equity firm that invests in companies across various industries, including life sciences. The firm provides growth capital and strategic support to its portfolio companies.

Merit Capital Partners

Kamylon Capital is a private equity firm that focuses on investing in middle-market companies. The firm has a diverse investment portfolio across different sectors, including life sciences.

Kamylon Capital

Rockport Capital is a venture capital firm that invests in companies driving innovation in energy, sustainability, and life sciences. The firm supports entrepreneurs and companies with a focus on creating positive environmental and social impact.

Rockport Capital

Oxford Science Enterprises is a venture capital firm that specializes in building and investing in life sciences companies. It focuses on scientific breakthroughs and transformative technologies that have the potential to create new industries or reshape existing ones. The firm provides capital, expertise, and access to a network of scientists, entrepreneurs, and industry experts to support the growth and development of its portfolio companies.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 7:43 AM	733e3088
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	f4c67de6
crunchbase profile	general
li profile	general	May 15, 2024 7:43 AM	828d763e
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:OXFORDSCIENCEENTERPRISES

Oxford Science Enterprises